Repeated administration of meta-chlorophenylpiperazine or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane produces tolerance to its stimulatory effect on adrenocorticotropin hormone but not prolactin or corticosterone secretion in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 782-789

  Mazzola Pomietto, Pascale ^a,b   Aulakh, Charanjit S ^a   Huang, Su Jan ^a   Murphy, Dennis L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b MSC 1264 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; CORTICOSTERONE; CORTICOTROPIN; PROLACTIN;

ANIMAL EXPERIMENT; ARTICLE; CORTICOSTERONE RELEASE; CORTICOTROPIN RELEASE; DOSE TIME EFFECT RELATION; DRUG CROSS TOLERANCE; DRUG EFFECT; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT;

ADRENOCORTICOTROPIC HORMONE; AMPHETAMINES; ANIMALS; CORTICOSTERONE; DRUG TOLERANCE; HYDROXYINDOLEACETIC ACID; HYPOTHALAMUS; MALE; PIPERAZINES; PROLACTIN; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS;

EID: 0030440955     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. 2 receptor in the 5-HT receptor-mediated stimulation of prolactin release. Eur. J. Pharmacol. 251: 157-161, 1994.
2. ALPER, R. H.: Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat. Neuroendocrinology. 51: 255-260, 1990.
3. 2 and 5-HT1C receptors in rat brain. J. Pharmacol. Exp. Ther. 255: 843-857, 1990.
4. AULAKH, C. S., HILL, J. L. AND MURPHY, D. L.: Effects of various serotonin receptor subtype selective antagonists alone and on m-CPP-induced neuroendocrine changes in rats. J. Pharmacol. Exp. Ther. 263: 588-595, 1992.
5. 2C receptors, respectively. Neuropsychopharmacology 13: 1-8, 1995.
6. 2A receptors. J. Pharmacol. Exp. Ther. 270: 127-132, 1994.
7. BAGDY, G., CALOGERO, A. E., MURPHY, D. L. AND SZEMEREDI, K.: Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology. 125: 2664-2669, 1989.
8. BAGDY, G., SVED, A. F., MURPHY, D. L. AND SZEMEREDI, K.: Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists. Eur. J. Pharmacol. 210: 285-289, 1992.
9. CALOGERO, A. E., BAGDY, G., SZEMEREDI, K., TARTAGLIA, M. E., GOLD, P. W. AND CHROUSOS, G. P.: Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 126: 1888-1894, 1990.
10. FULLER, R. W.: The involvement of serotonin in regulation of pituitary-adrenocortical function. Front. Neuroendocrinol. 13: 250-270, 1992.
11. FULLER, R. W., SNODDY, H. D., MASON, N. R. AND OWEN, J. E.: Disposition and pharmacological effects of m-chlorophenylpiperazine in rats. Neuropharmacology 20: 155-162, 1981a.
12. FULLER, R. W., SNODDY, H. D. AND MOLLOY, B. B.: Substituted piperazines as central serotonin agonists: Comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine. J. Pharmacol. Exp. Ther. 218: 636-641, 1981b.
13. 2 serotonin receptors. J. Med. Chem. 31: 5-7, 1988.
14. HO, B. T., ESTEVEZ, V. AND FRITCHIE, G. E.: The fate of 2,5-dimethoxy-4-methylamphetamine (STP, DOM) in monkey and rat brains. Brain Res. 29: 166-169, 1971a.
15. HO, B. T., ESTEVEZ, V., TANSEY, L. W., ENGLERT, L. F., CREAVEN, P. J. AND MCISAAC, W. M.: Analogs of amphetamine. 5. Studies of excretory metabolites of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats. J. Med. Chem. 14: 158-160, 1971b.
16. HOFFMAN, A. R., CEDA, G. AND REISINE, T. D.: Corticotropin-releasing factor desensitization of adrenocorticotropic hormone release is augmented by arginine vasopressin. J. Neurosci. 5: 234-242, 1985.
17. 1 recognition sites. J. Recept. Res. 8: 59-81, 1988.
18. 1c receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Naunyn-Schmiedeberg Arch. Pharmacol. 339: 252-258, 1989.
19. INVERNIZZI, R., COTECCHIA, S., DEBLASI, A., MENNINI, T., PATUCCINI, R. AND SAMANIN, R.: Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats. Neurochem. Int. 3: 239-244, 1981.
20. JULIUS, D., MACDERMOTT, A. B., AXEL, R. AND JESSELL, T. M.: Molecular characterization of a functional cDNA encoding the serotonin 1C receptor. Science 241: 558-564, 1988.
21. 2 receptor agonist DOI. Eur. J. Pharmacol. 221: 121-127, 1992.
22. LEVY, A. D. AND VAN DE KAR, L. D.: Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants. Life Sci. 51: 83-94, 1992.
23. 2A receptors. Psychopharmacology 117: 193-199, 1995.
24. 2C receptors. Psychopharmacology 123: 333-339, 1996.
25. MEFFORD, I. N.: Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: Measurement of catecholamines, serotonin and metabolites in rat brain. J. Neurosci. Methods 3: 207-224, 1981.
26. MILLER, R. L. AND DEVANE, C. L.: Analysis of trazodone and m-chlorophenylpiperazine in plasma and brain tissue by high-performance liquid chromatography. J. Chromatogr. 374: 388-393, 1986.
27. MULLER, E. E. AND NISTICO, G.: Brain Messengers and the Pituitary. Academic Press, San Diego, 1989.
28. MURPHY, D. L., MUELLER, E. A., HILL, J. L., TOLLIVER, T. J. AND JACOBSEN, F. M.: Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology, 98: 275-282, 1989.
29. 2 receptor-mediated temperature and corticosterone responses. Pharmacol. Biochem. Behav. 33: 781-785, 1989.
30. NEILL, J. D. AND REICHERT, L. E.: Development of a radioimmunoassay for rat prolactin and evaluation of the NIAMD rat prolactin radioimmunoassay. Endocrinology 88: 548-555, 1971.
31. NICHOLSON, W. E., DAVIS, D. R., SHERRELL, B. J. AND ORTH, D. N.: Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin. Chem. 30: 259-265, 1984.
32. 2 agonist, (±)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration. J. Pharmacol. Exp. Ther. 260: 795-800, 1991.
33. 2 receptor. EMBO J. 7: 4135-4140, 1988.
34. QUATTRONE, A., SCHETTINI, G., ANNUNZIATO, L. AND DIRENZO, G.: Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion. Eur. J. Pharmacol. 76: 9-13, 1981.
35. RITTENHOUSE, P. A., BAKKUM, E. A., HERBERT, G., BETHEA, C. L. AND VAN D. E. KAR, L. D.: Serotonin receptor subtypes mediating neuroendocrine responses to DOI. Pharmacologist 32: 185, 1990.
36. 2A/2C) receptors. J. Pharmacol. Exp. Ther. 271: 1647-1655, 1994.
37. 1C/2 receptors. Endocrinology 133: 661-667, 1993.
38. SILLS, M. A., LUCKI, I. AND FRAZER, A.: Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or m-CPP. Life Sci. 36: 2463-2469, 1985.
39. TITELER, M., LYON, R. A., DAVIS, K. H. AND GLENNON, R. A.: Selectivity of serotonergic drugs for multiple brain serotonin receptors. Biochem. Pharmacol. 36: 3265-3271, 1987.
40. ULRICHSEN, J., PARTILLA, J. S. AND DAX, E. M.: Long-term administration of m-chlorophenylpiperazine (m-CPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion. Psychopharmacology 107: 229-235, 1992.
41. UNDERWOOD, R. M. AND WILLIAMS, G. H.: The simultaneous measurement of aldosterone, cortisol and corticosterone in human peripheral plasma by displacement analysis. J. Lab. Clin. Med. 79: 848-862, 1972.
42. VAN DE KAR, L. D.: Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu. Rev. Pharmacol. Toxicol. 81: 289-320, 1991.
43. VAN DE KAR, L. D., BONADONNA, A. M., RITTENHOUSE, P. A., KERR, J. E., LEVY, A. D., IYER, L., HERBERT, G. B., SANZ, M. C. A., LENT, S. J. AND CARNES, M.: Prior chronic exposure to cocaine inhibits the serotonergic stimulation of ACTH and secretion of corticosterone. Neuropharmacology 31: 169-175, 1992.
44. VILARO, M. T., PALACIOS, J. M. AND MENGOD, G.: Neurotransmitter receptor histochemistry: The contribution of in situ hybridization. Life Sci. 57: 1141-1154, 1995.